PRTA (STOCKS)
Prothena Corporation plc Ordinary Shares
$8.930000
-0.030000 (-0.33%)
Prev close: $8.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene G. Kinney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $484.48M
- Employees
- 163
- P/E (TTM)
- -1.71
- P/B (TTM)
- 1.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.68 | $-0.70 | +0.0209 | +2.98% |
|
Jun 2025 (Q2)
|
$-1.73 | $-1.34 | -0.3874 | -28.85% |
|
Mar 2025 (Q1)
|
$-1.12 | $-0.99 | -0.1272 | -12.81% |
|
Dec 2024 (Q4)
|
$-1.08 | $-1.06 | -0.0172 | -1.62% |
Financial Statements
| Revenues | $11.79M |
| Benefits Costs and Expenses | $250.54M |
| Costs And Expenses | $250.54M |
| Nonoperating Income/Loss | $16.58M |
| Operating Expenses | $267.12M |
| Research and Development | $170.44M |
| Other Operating Expenses | $96.68M |
| Operating Income/Loss | -$255.33M |
| Income/Loss From Continuing Operations After Tax | -$280.46M |
| Income/Loss From Continuing Operations Before Tax | -$238.75M |
| Income Tax Expense/Benefit | $41.71M |
| Interest Income/Expense After Provision For Losses | $16.88M |
| Interest Income/Expense Operating, Net | $16.88M |
| Net Income/Loss | -$280.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$280.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$280.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$5.20 |
| Diluted Earnings Per Share | -$5.20 |
| Basic Average Shares | 107,672,000 |
| Diluted Average Shares | 107,672,000 |
| Assets | $352.63M |
| Current Assets | $339.97M |
| Noncurrent Assets | $12.65M |
| Fixed Assets | $2.46M |
| Other Non-current Assets | $10.19M |
| Liabilities | $57.64M |
| Current Liabilities | $51.44M |
| Accounts Payable | $10.50M |
| Wages | $7.66M |
| Other Current Liabilities | $33.28M |
| Noncurrent Liabilities | $6.20M |
| Equity | $294.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $294.99M |
| Liabilities And Equity | $352.63M |
| Net Cash Flow From Operating Activities | -$188.04M |
| Net Cash Flow From Operating Activities, Continuing | -$188.04M |
| Net Cash Flow From Investing Activities | -$181.00K |
| Net Cash Flow From Investing Activities, Continuing | -$181.00K |
| Net Cash Flow From Financing Activities | -$198.00K |
| Net Cash Flow From Financing Activities, Continuing | -$198.00K |
| Net Cash Flow | -$188.42M |
| Net Cash Flow, Continuing | -$188.42M |
| Comprehensive Income/Loss | -$280.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$280.46M |
| Other Comprehensive Income/Loss | $0.00 |